Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Osteogenesis inhibitory protein: a (p)review.

A G Brownell1

  • 1Department of Biology and Health Sciences, Chapman College, Orange, California 92666.

Connective Tissue Research
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Specific amelogenin gene splice products have signaling effects on cells in culture and in implants in vivo.

The Journal of biological chemistry·2000
Same author

Isolation, partial purification and in vitro characterization of osteogenic inhibitory protein.

Connective tissue research·1988
Same author

Preparation and bioassay of bone morphogenetic protein and polypeptide fragments.

Methods in enzymology·1987
Same author

Purification of bovine bone morphogenetic protein by hydroxyapatite chromatography.

Proceedings of the National Academy of Sciences of the United States of America·1984
Same author

Human bone morphogenetic protein (hBMP).

Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)·1983
Same author

Basal lamina persistence during epithelial-mesenchymal interactions in murine tooth development in vitro.

Journal of craniofacial genetics and developmental biology·1983
Same journal

Tissue zone dependence and asymmetric distribution of membrane ruffles of <i>in-situ</i> bovine chondrocytes.

Connective tissue research·2026
Same journal

Targeting extracellular collagen assembly to enhance functional recovery in composite neuromuscular trauma.

Connective tissue research·2026
Same journal

Ozonated water attenuates nucleus pulposus cell apoptosis and matrix degradation by suppressing NF-κB signaling in a rat model of <i>Staphylococcus aureus</i>-induced discitis.

Connective tissue research·2026
Same journal

Investigating the genetic basis of fibrotic pathway dysregulation in Dupuytren's contracture.

Connective tissue research·2026
Same journal

Kaempferol binds with NSUN2 to mediate RNA 5-methylcytosine modification of BMP2 in osteogenic differentiation.

Connective tissue research·2026
Same journal

Overexpression of NSUN3 suppresses ferroptosis in osteoarthritis chondrocytes by reducing m5C modification and expression of PCBP1 mRNA.

Connective tissue research·2026
See all related articles

Researchers discovered osteogenesis inhibitory protein (OIP), which inhibits bone morphogenetic protein (BMP) activity. This finding offers new insights into bone biology and potential therapeutic targets.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Orthopedics

Background:

  • Bone matrix contains biologically active factors influencing bone metabolism.
  • Bone morphogenetic protein (BMP) was the first identified factor with osteogenic properties.

Purpose of the Study:

  • To present an historical perspective of bone-derived biologically active factors.
  • To describe a newly identified protein that inhibits BMP activity.
  • To investigate the biological role and activities of this inhibitory protein.

Main Methods:

  • Historical review of bone matrix factors.
  • Biochemical fractionation to isolate proteins.
  • In vitro and in vivo assays to determine biological activity.
  • Preliminary antimitotic assays.

Related Experiment Videos

Main Results:

  • Identification of a protein that copurifies with BMP.
  • Demonstration of BMP inhibition by the novel protein, named osteogenesis inhibitory protein (OIP).
  • Preliminary evidence suggests OIP possesses antimitotic properties.

Conclusions:

  • Osteogenesis inhibitory protein (OIP) plays a crucial role in regulating BMP activity.
  • OIP's inhibitory and potential antimitotic functions warrant further investigation for therapeutic applications in bone diseases.